PeptidePedia The community reference

Aspiration risk under anaesthesia: difference between revisions

Diff·revision 8 → 9·14:11, 20 Feb 2025

Difference between revision 8 and revision 9 of Aspiration risk under anaesthesia. 5 lines changed; the page grew by 117 bytes.

Revision 8 — 20:37, 25 Jan 2025
SiteReactionSuz (talk)
flag the section as needing a source for two remaining figures
3,608 bytes +30
Revision 9 — 14:11, 20 Feb 2025
SPPS_Sorrel (talk)
split the gastrointestinal effects from the metabolic ones
3,725 bytes +117
38<ref name="marathe2013">Marathe CS, Rayner CK, Jones KL, Horowitz M. "Relationships between gastric emptying, postprandial glycemia, and incretin hormones." ''Diabetes Care'' 36(5):1396–1405 (2013). PMID 23613599.</ref>38<ref name="marathe2013">Marathe CS, Rayner CK, Jones KL, Horowitz M. "Relationships between gastric emptying, postprandial glycemia, and incretin hormones." ''Diabetes Care'' 36(5):1396–1405 (2013). PMID 23613599.</ref>
3939
+40== See also ==
+41* [[Gastric emptying]]
+42* [[Adverse effects of GLP-1 receptor agonists]]
+43* [[GLP-1 receptor agonist]]
+44
40{{DEFAULTSORT:Aspiration risk under anaesthesia}}45{{DEFAULTSORT:Aspiration risk under anaesthesia}}
41[[Category:Perioperative considerations]]46[[Category:Perioperative considerations]]